Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell PC, Bernardo J, King MD, Kawamura LM, Daley CL; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection Study Investigators. Jasmer RM, et al. Among authors: bernardo j. Clin Infect Dis. 2004 Feb 1;38(3):363-9. doi: 10.1086/380966. Epub 2004 Jan 13. Clin Infect Dis. 2004. PMID: 14727206 Clinical Trial.
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators. Jasmer RM, et al. Among authors: bernardo j. Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007. Ann Intern Med. 2002. PMID: 12379063 Clinical Trial.
An official ATS statement: hepatotoxicity of antituberculosis therapy.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR; ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. Saukkonen JJ, et al. Among authors: bernardo j. Am J Respir Crit Care Med. 2006 Oct 15;174(8):935-52. doi: 10.1164/rccm.200510-1666ST. Am J Respir Crit Care Med. 2006. PMID: 17021358 Review.
The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States.
Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, Bernardo J. Marks SM, et al. Among authors: bernardo j. Clin Infect Dis. 2013 Aug;57(4):532-42. doi: 10.1093/cid/cit336. Epub 2013 May 22. Clin Infect Dis. 2013. PMID: 23697743 Free PMC article.
Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.
Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL, Reves RR, Bernardo J, Campbell BH, Whitworth WC, Mazurek GH. Kellar KL, et al. Among authors: bernardo j. PLoS One. 2011;6(11):e26545. doi: 10.1371/journal.pone.0026545. Epub 2011 Nov 21. PLoS One. 2011. PMID: 22132075 Free PMC article.
253 results